Introduction

Research with human brain organoids and human-animal chimeras is significantly altering our ability to study the development and function of the human brain. What seemed like science fiction just a few years ago is now an experimental reality: human nerve cells can be cultured from stem cells, organized into three-dimensional structures that, in some respects, resemble brain tissue, and subsequently incorporated into the nervous system of laboratory animals.

In 2022, a study led by Sergiu Pașca of Stanford University showed that human brain organoids transplanted into newborn rats could functionally integrate into the animal’s brain. The human neurons established connections with the rat’s circuits and could respond to stimuli from its whiskers. The work opened new possibilities for studying neurological and psychiatric diseases, but it also raised a fundamental bioethical question: to what extent can the incorporation of human nerve tissue alter the capabilities of the recipient animal?

Four years later, in September 2026, the same group took a further step. Kaganovsky and colleagues developed genetically modified mice that prevented the normal development of the cerebral cortex and hippocampus and then filled the resulting space with human neuronal tissue derived from organoids. The result is a particularly advanced form of human-animal neural chimera, allowing researchers to study human neurons in a living brain, with connections to the rest of the body.

The interest in these experiments is undeniable. So too is the need to examine them from a bioethical perspective that goes beyond simply asking what benefits might be gained, and instead considers what kind of entity we are producing, what degree of human integration can be achieved, and what the limits of experimentation should be.

1. What are brain organoids and chimeras?

Brain organoids are three-dimensional structures derived from stem cells that, under specific culture conditions, can differentiate into various types of nerve cells and partially reproduce certain characteristics of human brain development. They are not complete human brains, nor do they replicate their full anatomical or functional organization, but they allow the study of processes that are very difficult to investigate directly in the human brain.

One of their fundamental limitations is that, when developed exclusively in the laboratory, they lack many of the conditions present in a living organism. Among other difficulties, they have limited vascularization and do not receive the complex sensory, hormonal, and metabolic information that accompanies normal brain development.

For this very reason, a different strategy has been developed: introducing human neural tissue into the brain of an animal. The recipient organism provides vascularization, nutrients, environmental signals, and connections to a complete nervous system.

When cells from different species contribute to the formation of an organism, it is called an interspecific chimera . In this context, a human-animal chimera is not necessarily an organism composed of equal parts human and animal cells. The percentage of human cells may be very small or concentrated in specific tissues. What is relevant is their functional integration.

The history of this research predates current experiments. The first mouse chimeras were created in the 1960s, while subsequent interspecies experiments with rats and mice demonstrated that cells from one species could contribute to the development of certain organs in another. In 2010, for example, rat cells were successfully used to contribute to the development of a mouse’s pancreas. More recently, organ complementation strategies using human cells in animals have been explored.

The ultimate goal of some of this research is to use animal organisms to generate tissues or organs that can be used to study diseases or, eventually, for transplants. However, the greater the contribution of human cells and the more complex the structures in which they participate, the greater the need to consider the ethical implications.

2. The 2022 experiment: a first step towards functional integration

In 2022, Pașca and his team used a different strategy than the one employed in 2026. Instead of genetically modifying the animal’s brain to make room for human tissue, they transplanted organoid-derived human neurons into the somatosensory cortex of newborn rats.

The choice of newborn animals was important. The rat brain is still in an intense phase of development and therefore offers greater possibilities for integration with human cells.

The human neurons did not remain isolated. They gradually integrated into the rat’s neural circuits and established connections with them. One of the most striking results was that the human neurons could respond to stimuli from the animal’s whiskers. In other words, these were not simply surviving human cells within a rat’s brain: there was functional integration with the host’s neural circuits.

The study also had a disease research component. Researchers produced organoids from cells of individuals with Timothy syndrome, a genetic disorder associated with neurological abnormalities and autism spectrum disorder, among other manifestations. The organoids derived from these patients showed differences in their growth and neuronal activity after transplantation.

The importance of this procedure lies in the fact that it allows the study of human cells in a much more complete biological environment than that provided by cell culture. In 2024, Pașca’s group also used this type of model to study treatments targeting alterations associated with Timothy syndrome.

But the 2022 model had a major limitation: the human cells had to compete for space with the rat brain. The rat tissue developed simultaneously and occupied most of the available space.

3. The 2026 leap: creating space for human brain tissue

The work published in Nature in September 2026 attempts to overcome precisely that limitation.

Kaganovsky and colleagues used genetic engineering to create mice incapable of developing certain brain structures normally, particularly the cerebral cortex and hippocampus. Then, when the animals were five to seven days old, they introduced human cortical tissue derived from brain organoids.

The experimental logic is simple, although its scientific consequences are extraordinary: if the mouse brain cannot generate certain neurons, there is a biological space that can be occupied by human neurons.

The results show considerable integration. The human tissue survived, developed, and established connections with the mouse’s nervous system. The study, published in Nature , also describes connections both from the human tissue to the animal’s brain structures and from the host’s circuits to the human tissue.

The extent of integration is greater than that achieved in previous models. According to information published in Nature , between two and three months after the transplant, the human tissue had increased considerably and occupied more than 90% of the experimentally created available brain space. Nerve projections were also observed extending to deep regions and even to the spinal cord.

Molecular analysis revealed different human cell populations, including cortical excitatory neurons, progenitor cells, and glial lineage cells. The maturation characteristics of the human neurons roughly corresponded to stages of second-trimester fetal human cortical development.

One particularly interesting finding was the appearance of cells similar to von Economo neurons, a specialized neuronal type that has been linked to certain cognitive and social functions and which until now had not appeared in this way in culture models.

4. Is it really a “mouse with a human brain”?

The expression is appealing, but from a scientific point of view it should be used with caution.

The very title of a popular science article on the subject, “A Mouse with a Human Brain ,” is intended to draw attention to the magnitude of the experiment. However, the resulting animal does not possess a complete human brain. Nor can it be considered a human brain transplanted into a mouse.

What exists is a human-mouse neural chimera , in which a considerable portion of the brain tissue is derived from human cells but remains integrated within a mouse organism. Furthermore, the architecture of the human tissue does not fully replicate the organization of a mature human cerebral cortex.

The 2026 study found that the human tissue did not develop the exact laminar organization characteristic of the human cerebral cortex. The animals were also not identical to normal controls. Certain alterations were observed, including gait abnormalities under hypoxic conditions.

Therefore, speaking of “a human brain” should be understood as a popular expression that points to the extraordinary human contribution to the animal’s brain tissue, not as a literal anatomical description.

5. What does this model contribute scientifically?

The main interest of the model is not to produce animals with human capabilities, but to have an experimental system that allows the study of human neurons in a living organism.

Organoids allow researchers to investigate aspects of human brain development, but their isolation from the organism is a limitation. A living brain provides blood circulation, metabolism, hormonal signals, sensory activity, interaction with other organs, and behavioral experience.

The 2026 model thus allows us to study how human neurons develop, connect, and function within a complete nervous system. This can be especially relevant for neurodevelopmental diseases and neurological disorders in which the alterations do not depend solely on an isolated neuron, but rather on the organization of circuits.

It can also facilitate the evaluation of certain treatments. The possibility of introducing patient-derived cells into a living model opens a way to study specific alterations and experimentally verify therapeutic responses.

In this sense, the evolution between 2022 and 2026 is significant: in 2022 it was shown that human neurons could be functionally integrated into the brain of a rat; in 2026 it has been possible to provide these cells with a much larger brain territory, reducing competition with the host cells.

6. The ethical question: what happens when human integration increases?

In reality, it’s not just a matter of considering the benefit to patients; we must start from the premise of what kind of action we are undertaking. Certainly, as the Bioethics Observatory of the Catholic University of Valencia points out , the production of human-animal chimeras entails ethical difficulties related, among other aspects, to the degree of colonization achieved by the chimera. This issue becomes even more relevant in light of recent advances, since experiments carried out in 2026 achieved a much more extensive integration of human neuronal tissue into the brain of a mouse, to the point that the human neurons contributed significantly to the functional reconstruction of brain regions that the animal could not develop on its own.

In April 2021, the U.S. National Academies of Sciences, Engineering, and Medicine published the report ” The Emerging Field of Human Neural Organoids, Transplants, and Chimeras: Science, Ethics, and Governance ,” which warned that research with organoids, neural transplants, and human-animal chimeras raised ethical questions related to the potential modification of animals’ capabilities and the possibility that the incorporation of human cells could alter aspects of their experience, consciousness, or mental capacities. The report noted that these concerns became especially important as the integration of human cells into the brains of animals increased and that they should be monitored as research progressed.

This concern is particularly significant today. While in 2021 it was raised as an issue that needed to be considered in the potential future development of these techniques, by 2026 we are already seeing experiments in which a very significant proportion of certain brain structures in animals originate from human neurons. Current results do not allow us to conclude that these animals have acquired human consciousness or human cognitive abilities; however, they do show that human neurons can functionally integrate into the animal’s nervous system and perform functions that would normally correspond to the animal’s own neurons.

On the other hand, a publication on human-animal chimeras asserts that “experiments combining human and non-human elements determine that the cells used can affect the brain and reproductive capacity, that is, those organs that particularly impact species identity and human unity,” and highlights “the grave danger of producing human-animal hybrids, since (…) we are faced with a monster in the broadest sense of the word, which is something unjust to do.” This consideration retains its relevance as an expression of bioethical concern about the mixing of human and non-human elements, although current scientific advances suggest focusing attention, with increasing precision, on the degree of integration achieved and its possible consequences for the animal’s capabilities.

Ultimately, the end never justifies the means. The dignity of the human person is inherent in human nature and cannot be disregarded. Therefore, these experiments must be subjected to ethical consideration that goes beyond simply assessing their potential therapeutic benefits. The increasing ability to integrate human nerve cells into animals makes it even more crucial to question the nature of our actions and the limits that should not be exceeded. Not everything that is possible is in accordance with the very essence of humanity.